Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms

Akinc, Akin, Querbes, William, De, Soma, Qin, June, Frank-Kamenetsky, Maria, Jayaprakash, K. Narayanannair, Jayaraman, Muthusamy, Rajeev, Kallanthottathil G +17 more·2010·Molecular Therapy
DOI 10.1038/mt.2010.85

Cited by (1,002)

Items 301–400 of 1,002

  1. Frameworks for transformational breakthroughs in RNA-based medicines
    John R. Androsavich · 2024 · Nature Reviews Drug Discovery
  2. Branching Ionizable Lipids Can Enhance the Stability, Fusogenicity, and Functional Delivery of mRNA
    Kazuki Hashiba, Yusuke Sato, Masamitsu Taguchi, Sachiko Sakamoto, Ayaka Otsu, Yoshiki Maeda, Takuya Shishido, Masao Murakawa, Okazaki Arimichi, Hideyoshi Harashima · 2022 · Small Science
  3. Personalized Cancer Nanomedicine: Overcoming Biological Barriers for Intracellular Delivery of Biopharmaceuticals
    Ana M. López-Estévez, Philipp Lapuhs, Laura Pineiro‐Alonso, Marı́a José Alonso · 2023 · Advanced Materials
  4. Synthetic Nucleic Acid Delivery Systems: Present and Perspectives
    Bogdan Draghici, Marc Antoniu Ilies · 2015 · Journal of Medicinal Chemistry
  5. A New Era for Rare Genetic Diseases: Messenger RNA Therapy
    Paolo G.V. Martini, Lin T. Guey · 2019 · Human Gene Therapy
  6. Nucleic Acid Drugs—Current Status, Issues, and Expectations for Exosomes
    Yoji Yamada · 2021 · Cancers
  7. Chemistry and Art of Developing Lipid Nanoparticles for Biologics Delivery: Focus on Development and Scale-Up
    Rijo John, Jasmin monpara, Shankar Swaminathan, Rahul S. Kalhapure · 2024 · Pharmaceutics
  8. Lactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma
    Mengzi Zhang, Xiaoju Zhou, Bo Wang, Bryant C. Yung, Ly J. Lee, Kalpana Ghoshal, Robert J. Lee · 2013 · Journal of Controlled Release
  9. Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo
    Justin B. Lee, Kaixin Zhang, Yuen Yi C. Tam, Ying K. Tam, Nathan M. Belliveau, Vanessa Y.C. Sung, Paulo J.C. Lin, Eric LeBlanc, Marco A. Ciufolini, Paul S. Rennie et al. · 2011 · International Journal of Cancer
  10. Interface Engineering in Multiphase Systems toward Synthetic Cells and Organelles: From Soft Matter Fundamentals to Biomedical Applications
    Zhou Liu, Wen You Zhou, Qi Cheng, Tiantian Kong · 2020 · Advanced Materials
  11. Functionalized lipid nanoparticles for subcutaneous administration of mRNA to achieve systemic exposures of a therapeutic protein
    Nigel M. Davies, Daniel Hovdal, Nicholas J. Edmunds, Peter Nordberg, Anders Dahlén, Aleksandra P. Dabkowska, Marianna Yanez Arteta, Aurel Rădulescu, Tomas Kjellman, Andreas Höijer et al. · 2021 · Molecular Therapy — Nucleic Acids
  12. siRNA Functionalized Lipid Nanoparticles (LNPs) in Management of Diseases
    Tutu Kalita, Saba Abbasi Dezfouli, Lalit Mohan Pandey, Hasan Uludağ · 2022 · Pharmaceutics
  13. Gene Therapy for Regenerative Medicine
    Hossein Hosseinkhani, Abraham Jacob Domb, Ghorbanali Sharifzadeh, Victoria Nahum · 2023 · Pharmaceutics
  14. Interaction Kinetics of Individual mRNA-Containing Lipid Nanoparticles with an Endosomal Membrane Mimic: Dependence on pH, Protein Corona Formation, and Lipoprotein Depletion
    Nima Aliakbarinodehi, Audrey Gallud, Mokhtar Mapar, Emelie V. Wesén, Sahar Heydari, Yujia Jing, Gustav Emilsson, Kai Liu, Alan Sabirsh, Vladimir P. Zhdanov et al. · 2022 · ACS Nano
  15. The role of protein corona on nanodrugs for organ-targeting and its prospects of application
    Sijie Wang, Junlei Zhang, Huan‐Li Zhou, Yi Chao Lu, Xizhi Jin, Lihua Luo, You Jian · 2023 · Journal of Controlled Release
  16. Relationship Between the Physicochemical Properties of Lipid Nanoparticles and the Quality of siRNA Delivery to Liver Cells
    Yusuke Sato, Hiroto Hatakeyama, Mamoru Hyodo, Hideyoshi Harashima · 2015 · Molecular Therapy
  17. High‐Contrast Fluorescence Detection of Metastatic Breast Cancer Including Bone and Liver Micrometastases via Size‐Controlled pH‐Activatable Water‐Soluble Probes
    Hu Xiong, Hao Zuo, Yunfeng Yan, Gino Occhialini, Kejin Zhou, Yihong Wan, Daniel J. Siegwart · 2017 · Advanced Materials
  18. mRNA lipid nanoparticle phase transition
    Marius F.W. Trollmann, Rainer A. Böckmann · 2022 · Biophysical Journal
  19. Nanoparticles for vaccine and gene therapy: Overcoming the barriers to nucleic acid delivery
    Lara M. Mollé, Cameron H. Smyth, Daniel Yuen, Angus P. R. Johnston · 2022 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
  20. From Phage Display to Nanoparticle Delivery: Functionalizing Liposomes with Multivalent Peptides Improves Targeting to a Cancer Biomarker
    Bethany Powell Gray, Shunzi Li, Kathlynn C. Brown · 2012 · Bioconjugate Chemistry
  21. Testing thousands of nanoparticles in vivo using DNA barcodes
    Melissa P. Lokugamage, Cory D. Sago, James E. Dahlman · 2018 · Current Opinion in Biomedical Engineering
  22. RNA delivery biomaterials for the treatment of genetic and rare diseases
    Zhao, Weiyu, Hou, Xucheng, Vick, Olivia G., Dong, Yizhou · 2019 · Biomaterials
  23. Optimizing synthetic nucleic acid and protein nanocarriers: The chemical evolution approach
    Franziska Freitag, Ernst Wagner · 2020 · Advanced Drug Delivery Reviews
  24. Expanding RNAi to Kidneys, Lungs, and Spleen via Selective ORgan Targeting (SORT) siRNA Lipid Nanoparticles
    Amogh Vaidya, Stephen Moore, Sumanta Chatterjee, Erick Damian Guerrero, Minjeong Kim, Lukas Farbiak, Sean A. Dilliard, Daniel J. Siegwart · 2024 · Advanced Materials
  25. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide
    Yao Lv, Lei Tao, S. W. Annie Bligh, Huihui Yang, Qixia Pan, Li‐Min Zhu · 2015 · Materials Science and Engineering C
  26. In Vivo Introduction of mRNA Encapsulated in Lipid Nanoparticles to Brain Neuronal Cells and Astrocytes via Intracerebroventricular Administration
    Tanaka, Hiroki, Nakatani, Taichi, Furihata, Tomomi, Tange, Kota, Nakai, Yuta, Yoshioka, Hiroki, Harashima, Hideyoshi, Akita, Hidetaka · 2018 · Molecular Pharmaceutics
  27. Lipid Nanoparticle (LNP) Chemistry Can Endow Unique In Vivo RNA Delivery Fates within the Liver That Alter Therapeutic Outcomes in a Cancer Model
    Lindsay T. Johnson, Di Zhang, Kejin Zhou, Sang M. Lee, Shuai Liu, Sean A. Dilliard, Lukas Farbiak, Sumanta Chatterjee, Yu-Hsuan Lin, Daniel J. Siegwart · 2022 · Molecular Pharmaceutics
  28. Bile acid-containing lipid nanoparticles enhance extrahepatic mRNA delivery
    Savan K. Patel, Margaret M. Billingsley, Alvin J. Mukalel, Ajay S. Thatte, Alex G. Hamilton, Ningqiang Gong, Rakan D. El-Mayta, Hannah C. Safford, Maria I. Merolle, Michael J. Mitchell · 2023 · Theranostics
  29. Cationic cholesterol-dependent LNP delivery to lung stem cells, the liver, and heart
    Afsane Radmand, Hyejin Kim, Jared P. Beyersdorf, Curtis N. Dobrowolski, Ryan Zenhausern, Kalina Paunovska, Sebastian G. Huayamares, Xuanwen Hua, Keyi Han, David Loughrey et al. · 2024 · Proceedings of the National Academy of Sciences
  30. Microfluidic self-assembly of folate-targeted monomolecular siRNA-lipid nanoparticles
    Rafał Krzysztoń, B. Salem, Dian-Jang Lee, Gerlinde Schwake, Ernst Wagner, Joachim Oskar Rädler · 2017 · Nanoscale
  31. iRGD-guided Tumor-penetrating Nanocomplexes for Therapeutic siRNA Delivery to Pancreatic Cancer
    Justin Han-Je Lo, Liangliang Hao, Mandar Deepak Muzumdar, Srivatsan Raghavan, Ester J. Kwon, Emilia M. Pulver, Felicia Hsu, Andrew J. Aguirre, Brian Matthew Wolpin, Charles S. Fuchs et al. · 2018 · Molecular Cancer Therapeutics
  32. mRNA in cancer immunotherapy: beyond a source of antigen
    Lien Van Hoecke, Rein Verbeke, Heleen Dewitte, Ine Lentacker, Karim Y. Vermaelen, Karine Breckpot, Sandra Van Lint · 2021 · Molecular Cancer
  33. Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics
    Sean C. Semple, Robert D. Leone, Christopher Barbosa, Ying K. Tam, Paulo J.C. Lin · 2022 · Pharmaceutics
  34. Design and lyophilization of lipid nanoparticles for mRNA vaccine and its robust immune response in mice and nonhuman primates
    Yuta Suzuki, Takayuki Miyazaki, Hiroki Muto, Kenji Kubara, Yohei Mukai, Ryuji Watari, Shinya Sato, Keita Kondo, Shin‐ichi Tsukumo, Koji Yasutomo et al. · 2022 · Molecular Therapy — Nucleic Acids
  35. Effect of Cholesterol Content of Lipid Composition in mRNA-LNPs on the Protein Expression in the Injected Site and Liver After Local Administration in Mice
    Maho Kawaguchi, Marin Noda, Akari Ono, Mariko Kamiya, Makoto Matsumoto, Masako Tsurumaru, Shusaku Mizukami, Hidefumi Mukai, Shigeru Kawakami · 2022 · Journal of Pharmaceutical Sciences
  36. Mechanistic Studies of an Automated Lipid Nanoparticle Reveal Critical Pharmaceutical Properties Associated with Enhanced mRNA Functional Delivery In Vitro and In Vivo
    Lili Cui, Morag Rose Hunter, Silvia Sonzini, Sara G. T. Pereira, Steven M. Romanelli, Kai Liu, Weimin Li, Lihuan Liang, Bin Yang, Najet Mahmoudi et al. · 2021 · Small
  37. Current advances in non‐viral gene delivery systems: Liposomes versus extracellular vesicles
    Belhadj, Zakia, Qie, Yunkai, Carney, Randy P., Li, Yuanpei, Nie, Guangjun · 2023 · BMEMat
  38. A neutral lipid envelope-type nanoparticle composed of a pH-activated and vitamin E-scaffold lipid-like material as a platform for a gene carrier targeting renal cell carcinoma
    Hidetaka Akita, Ryohei Ishiba, Ryohei Togashi, Kota Tange, Yuta Nakai, Hiroto Hatakeyama, Hideyoshi Harashima · 2014 · Journal of Controlled Release
  39. The systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in mice
    Hiroto Hatakeyama, Manami Murata, Yusuke Sato, Mayumi M. Takahashi, Noriaki Minakawa, Akira Matsuda, Hideyoshi Harashima · 2013 · Journal of Controlled Release
  40. The liver sieve and atherosclerosis
    R. Fraser, V. Cogger, B. Dobbs, H. Jamieson, A. Warren, S. Hilmer, D. Le Couteur · 2012 · Pathology (Sydney)
  41. Efficient hepatic delivery and protein expression enabled by optimized mRNA and ionizable lipid nanoparticle
    Tongren Yang, Chunhui Li, Xiaoxia Wang, Deyao Zhao, Mengjie Zhang, Huiqing Cao, Zicai Liang, Haihua Xiao, Xing‐Jie Liang, Yuhua Weng et al. · 2020 · Bioactive Materials
  42. Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery
    Magdalena M. Żak, Lior Zangi · 2021 · Pharmaceutics
  43. Cholesterol-Mediated Seeding of Protein Corona on DNA Nanostructures for Targeted Delivery of Oligonucleotide Therapeutics to Treat Liver Fibrosis
    Kyoung‐Ran Kim, Junghyun Kim, Ji Hyun Back, Ji Eun Lee, Dae‐Ro Ahn · 2022 · ACS Nano
  44. Nanoparticulate Drug Delivery in Pregnancy: Placental Passage and Fetal Exposure
    Vinith Menezes, Antoine Malek, Jeffrey A. Keelan · 2011 · Current Pharmaceutical Biotechnology
  45. Disposition and Pharmacokinetics of a GalNAc3-Conjugated Antisense Oligonucleotide Targeting Human Lipoprotein (a) in Monkeys
    Rosie Z. Yu, Rudy Gunawan, Noah M. Post, Thomas A. Zanardi, Shannon Hall, Jennifer Burkey, Tae‐Won Kim, Mark J. Graham, Thazha P. Prakash, Punit P. Seth et al. · 2016 · Nucleic Acid Therapeutics
  46. The Extent to Which Lipid Nanoparticles Require Apolipoprotein E and Low-Density Lipoprotein Receptor for Delivery Changes with Ionizable Lipid Structure
    Kalina Paunovska, Alejandro J. Da Silva Sanchez, Melissa P. Lokugamage, David Loughrey, Elisa Schrader Echeverri, Ana Cristian, Marine Z. C. Hatit, Philip J. Santangelo, Kun Zhao, James E. Dahlman · 2022 · Nano Letters
  47. mRNA therapeutics: New vaccination and beyond
    Huanhuan Y. Wei, Liangliang Zheng, Zefeng Wang · 2023 · Fundamental Research
  48. Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo
    Johanna Walther, Deja Porenta, Danny Wilbie, Cornelis W. Seinen, Naomi Benne, Qiangbing Yang, Olivier G. de Jong, Zhiyong Lei, Enrico Mastrobattista · 2024 · European Journal of Pharmaceutics and Biopharmaceutics
  49. Surface engineering of lipid nanoparticles: targeted nucleic acid delivery and beyond
    Yi Lin, Qiang Cheng, Tuo Wei · 2023 · Biophysics Reports
  50. Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems
    Liu, Jie, Liu, Jinhu, Mu, Weiwei, Ma, Qingping, Zhai, Xiangyu, Jin, Bin, Liu, Yongjun, Zhang, Na · 2024 · ACS Nano
  51. Targeting Therapeutics to the Glomerulus With Nanoparticles
    Jonathan E. Zuckerman, Mark E. Davis · 2013 · Advances in Chronic Kidney Disease
  52. Protein Binding Affinity of Polymeric Nanoparticles as a Direct Indicator of Their Pharmacokinetics
    Zhiting Cao, Li-Qin Gan, Wei Jiang, Jilong Wang, Houbing Zhang, Yue Zhang, Yucai Wang, Xianzhu Yang, Menghua Xiong, Jun Wang · 2020 · ACS Nano
  53. Predictive high-throughput screening of PEGylated lipids in oligonucleotide-loaded lipid nanoparticles for neuronal gene silencing
    Apoorva Sarode, Yuchen Fan, Amy E. Byrnes, Michal Hammel, Greg L. Hura, Yige Fu, Ponien Kou, Chloe Hu, Flora I. Hinz, Jasmine Roberts et al. · 2022 · Nanoscale Advances
  54. Cell‐penetrating peptides: A tool for effective delivery in gene‐targeted therapies
    Inês Rego de Figueiredo, João Miguel Freire, Luis R. Flores, Ana Salomé Veiga, Miguel A. R. B. Castanho · 2014 · IUBMB Life
  55. MicroRNAs and Drug Resistance in Prostate Cancers
    Feng Li, Ram I. Mahato · 2014 · Molecular Pharmaceutics
  56. Preparation of novel curdlan nanoparticles for intracellular siRNA delivery
    Jingfen Han, Jia Cai, Wuyinga Borjihan, Tsogzolmaa Ganbold, Tariq M. Rana, Huricha Baigude · 2014 · Carbohydrate Polymers
  57. Cationic Lipid-Coated Gold Nanoparticles as Efficient and Non-Cytotoxic Intracellular siRNA Delivery Vehicles
    Won Ho Kong, Ki Hyun Bae, Sung Duk Jo, Jee Seon Kim, Tae Gwan Park · 2011 · Pharmaceutical Research
  58. Lipid nanoparticles for hepatic delivery of small interfering RNA
    Bo Yu, Shu‐Hao Hsu, Chenguang Zhou, Xinmei Wang, Megan Cavanaugh Terp, Yun Wu, Lesheng Teng, Yicheng Mao, Feng Wang, Weiming Xue et al. · 2012 · Biomaterials
  59. siRNA-lipid nanoparticles with long-term storage stability facilitate potent gene-silencing in vivo
    Suzuki, Y., Hyodo, K., Tanaka, Y., Ishihara, H. · 2015 · Journal of Controlled Release
  60. The Transcriptional Response to Lung-Targeting Lipid Nanoparticles in Vivo
    Afsane Radmand, Melissa P. Lokugamage, Hyejin Kim, Curtis N. Dobrowolski, Ryan Zenhausern, David Loughrey, Sebastian G. Huayamares, Marine Z. C. Hatit, Huanzhen Ni, Ada Del Cid et al. · 2023 · Nano Letters
  61. Lipid shape and packing are key for optimal design of pH-sensitive mRNA lipid nanoparticles
    Giulio Tesei, Ya‐Wen Hsiao, Aleksandra P. Dabkowska, Gunnar Grönberg, Marianna Yanez Arteta, David Ulkoski, David J. Bray, Martin Trulsson, Johan Ulander, Mikael Lund et al. · 2024 · Proceedings of the National Academy of Sciences
  62. mRNA-based therapeutics–Advances and perspectives
    Olga V. Sergeeva, Victor Koteliansky, Timofei S. Zatsepin · 2016 · Biochemistry (Moscow)
  63. mRNA Therapy Improves Metabolic and Behavioral Abnormalities in a Murine Model of Citrin Deficiency
    Cao, Jingsong, An, Ding, Galduroz, Mikel, Zhuo, Jenny, Liang, Shi, Eybye, Marianne, Frassetto, Andrea, Kuroda, Eishi, Funahashi, Aki, Santana, Jordan et al. · 2019 · Molecular Therapy
  64. Translation of angiotensin-converting enzyme 2 upon liver-and lung-targeted delivery of optimized chemically modified mRNA
    Schrom, Eva, Huber, Maja, Aneja, Manish, Dohmen, Christian, Emrich, Daniela, Geiger, Johannes, Hasenpusch, Günther, Herrmann-Janson, Annika, Kretzschmann, Verena, Mykhailyk, Olga et al. · 2017 · Molecular Therapy — Nucleic Acids
  65. Leveraging Biological Buffers for Efficient Messenger RNA Delivery via Lipid Nanoparticles
    Michael I. Henderson, Yulia Eygeris, Antony Jozić, Marco Herrera‐Barrera, Gaurav Sahay · 2022 · Molecular Pharmaceutics
  66. Nanoparticle stereochemistry-dependent endocytic processing improves in vivo mRNA delivery
    Marine Z. C. Hatit, Curtis N. Dobrowolski, Melissa P. Lokugamage, David Loughrey, Huanzhen Ni, Chiara Zurla, Alejandro J. Da Silva Sanchez, Afsane Radmand, Sebastian G. Huayamares, Ryan Zenhausern et al. · 2023 · Nature Chemistry
  67. Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach
    Rachel E. Young, Katherine M. Nelson, Samuel I. Hofbauer, Tara Vijayakumar, Mohamad‐Gabriel Alameh, Drew Weissman, Charalampos Papachristou, Jason P. Gleghorn, Rachel Riley · 2023 · Bioactive Materials
  68. Ionizable lipid-assisted efficient hepatic delivery of gene editing elements for oncotherapy
    Chunhui Li, Tongren Yang, Yuhua Weng, Mengjie Zhang, Deyao Zhao, Shuai Guo, Bo Hu, Wanxuan Shao, Xiaoxia Wang, Abid Hussain et al. · 2021 · Bioactive Materials
  69. Development of a high-throughput platform for screening lipid nanoparticles for mRNA delivery
    Lili Cui, Sara G. T. Pereira, Silvia Sonzini, Sally van Pelt, Steven M. Romanelli, Lihuan Liang, David Ulkoski, Venkata Ramanan Krishnamurthy, Emily Brannigan, Christopher Brankin et al. · 2022 · Nanoscale
  70. Ionizable Lipid Nanoparticles for mRNA Delivery
    Xuefeng Tang, Ying Zhang, Xiaojun Han · 2023 · Advanced NanoBiomed Research
  71. Identification of siRNA delivery enhancers by a chemical library screen
    Jérôme Gilleron, Prasath Paramasivam, Anja Zeigerer, William Querbes, Giovanni Marsico, Cordula Andree, Sarah Seifert, Pablo Amaya, Martin Stöter, Victor Koteliansky et al. · 2015 · Nucleic Acids Research
  72. Mechanism of Macromolecular Structure Evolution in Self-Assembled Lipid Nanoparticles for siRNA Delivery
    Marian E. Gindy, Katherine DiFelice, Varun Kumar, Robert K. Prud’homme, Robert Celano, R. Matthew Haas, Jeffrey S. Smith, David Boardman · 2014 · Langmuir
  73. Using Large Datasets to Understand Nanotechnology
    Kalina Paunovska, David Loughrey, Cory D. Sago, Róbert Langer, James E. Dahlman · 2019 · Advanced Materials
  74. Gene editing and its applications in biomedicine
    Guanglei Li, Xiangyang Li, Songkuan Zhuang, Liren Wang, Yifan Zhu, Yangcan Chen, Wen Ce Sun, Zeguang Wu, Zhuo Long Zhou, Jia Chen et al. · 2022 · Science China Life Sciences
  75. Aerosol delivery of stabilized polyester-siRNA nanoparticles to silence gene expression in orthotopic lung tumors
    Yunfeng Yan, Kejin Zhou, Hu Xiong, Jason B. Miller, Edward A. Motea, David A. Boothman, Li Liu, Daniel J. Siegwart · 2016 · Biomaterials
  76. mRNA: A promising platform for cancer immunotherapy
    Byoungjae Kong, Yelee Kim, Eun Hye Kim, Jung Soo Suk, Yoosoo Yang · 2023 · Advanced Drug Delivery Reviews
  77. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery
    Neeraj Prabhakar, Jixi Zhang, Diti Desai, Eudald Casals, Tina Gulin-Sarfraz, Tuomas Näreoja, Jukka K. Westermarck, Jessica M. Rosenholm · 2016 · International Journal of Nanomedicine
  78. Targeting aging and age-related diseases with vaccines
    Wu, Ruochen, Sun, Fei, Zhang, Weiqi, Ren, Jie, Liu, Guang-Hui · 2024 · Nature Aging
  79. Targeted delivery of oligonucleotides using multivalent protein–carbohydrate interactions
    Vajinder Kumar, W. Bruce Turnbull · 2023 · Chemical Society Reviews
  80. A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics
    Sheyda Ranjbar, Xiao‐bo Zhong, José Enrique Manautou, Xiuling Lü · 2023 · Advanced Drug Delivery Reviews
  81. The role of patient-specific variables in protein corona formation and therapeutic efficacy in nanomedicine
    Ethan P. Cisneros, Brinkley A. Morse, Ani Savk, Khyati Malik, Nicholas A. Peppas, Olivia L. Lanier · 2024 · Journal of Nanobiotechnology
  82. Delivery of mRNA for regulating functions of immune cells
    Jia Yu Shi, Mengwen Huang, Zi-Dong Lu, Xiao‐Jiao Du, Song Shen, Cong‐Fei Xu, Jun Wang · 2022 · Journal of Controlled Release
  83. Recent Update on siRNA Therapeutics
    Oluwakemi Ebenezer, Abel Kolawole Oyebamiji, John Oludele Olanlokun, Jack A. Tuszyński, Gane Ka‐Shu Wong · 2025 · International Journal of Molecular Sciences
  84. Herbal and polymeric approaches for liver-targeting drug delivery: novel strategies and their significance
    Raman Rohilla, Tarun Garg, Amit K. Goyal, Goutam Rath · 2014 · Drug Delivery
  85. Naturally Derived Membrane Lipids Impact Nanoparticle-Based Messenger RNA Delivery
    Kim, Jeonghwan, Jozic, Antony, Sahay, Gaurav · 2020 · Cellular and Molecular Bioengineering
  86. Hypoxia-sensitive micellar nanoparticles for co-delivery of siRNA and chemotherapeutics to overcome multi-drug resistance in tumor cells
    Ujjwal Joshi, Nina Filipczak, Muhammad Muzamil Khan, Sara Aly Attia, Vladimir P. Torchilin · 2020 · International Journal of Pharmaceutics
  87. Delivery technologies for in utero gene therapy
    Palanki, Rohan, Peranteau, William H., Mitchell, Michael J. · 2021 · Advanced Drug Delivery Reviews
  88. Clinical applications of gene therapy for rare diseases: A review
    Ioannis Papaioannou, James Stuart Owen, Rafael J. Yáñez‐Muñoz · 2023 · International Journal of Experimental Pathology
  89. Advances and prospects of RNA delivery nanoplatforms for cancer therapy
    Mohamed S. Attia, Gregor Stefan Kijanka, Nam‐Trung Nguyen, Jun Zhang, Hongjie An · 2024 · Acta Pharmaceutica Sinica B
  90. Tissue-specific mRNA delivery and prime editing with peptide–ionizable lipid nanoparticles
    Yi Lin, Mengyao Li, Zijin Luo, Yanan Meng, Yan Zong, Hongyu Ren, Xiaolu Yu, Xiaoqiong Tan, Fan Liu, Tuo Wei et al. · 2025 · Nature Materials
  91. Drug Targeting to Infectious Diseases by Nanoparticles Surface Functionalized with Special Biomolecules
    Shyam Sundar, Vijay Kumar Prajapati · 2012 · Current Medicinal Chemistry
  92. Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin
    Shanthi Ganesh, Martin L. Koser, Wendy A. Cyr, Girish Rajmal Chopda, Junyan Tao, Xue Shui, Bo Ying, Dongyu Chen, Purva Pandya, Edmond Chipumuro et al. · 2016 · Molecular Cancer Therapeutics
  93. Therapeutic mRNA delivery to leukocytes
    Yasmin Granot-Matok, Edo Kon, Niels Dammes, Gilad Mechtinger, Dan Peer · 2019 · Journal of Controlled Release
  94. Polymer–Lipid Nanoparticles for Systemic Delivery of mRNA to the Lungs
    Kaczmarek, James C., Patel, Asha K., Kauffman, Kevin J., Fenton, Owen S., Webber, Matthew J., Heartlein, Michael W., DeRosa, Frank, Anderson, Daniel G. · 2016 · Angewandte Chemie
  95. Medicinal Chemistry of siRNA Delivery
    Matthew G. Stanton, Steven L. Colletti · 2010 · Journal of Medicinal Chemistry
  96. Universal Barcoding Predicts In Vivo ApoE-Independent Lipid Nanoparticle Delivery
    Alejandro J. Da Silva Sanchez, Curtis N. Dobrowolski, Ana Cristian, Elisa Schrader Echeverri, Kun Zhao, Marine Z. C. Hatit, David Loughrey, Kalina Paunovska, James E. Dahlman · 2022 · Nano Letters
  97. Enhancing the Effectiveness of Oligonucleotide Therapeutics Using Cell-Penetrating Peptide Conjugation, Chemical Modification, and Carrier-Based Delivery Strategies
    Saeed Anwar, Farin Mir, Toshifumi Yokota · 2023 · Pharmaceutics
  98. A Glu-urea-Lys Ligand-conjugated Lipid Nanoparticle/siRNA System Inhibits Androgen Receptor Expression In Vivo
    Justin B. Lee, Kaixin Zhang, Yuen Yi C. Tam, Joslyn Quick, Ying K. Tam, Paulo J.C. Lin, Sam Chen, Yan Liu, Jayaprakash K. Nair, Ivan Zlatev et al. · 2016 · Molecular Therapy — Nucleic Acids
  99. Investigating the Impact of Delivery System Design on the Efficacy of Self-Amplifying RNA Vaccines
    Giulia Anderluzzi, Gustavo Lou, Simona Gallorini, Michela Brazzoli, Russell Johnson, Derek T. O’Hagan, Barbara C. Baudner, Yvonne Perrie · 2020 · Vaccines
  100. siRNA as a tool to improve the treatment of brain diseases: Mechanism, targets and delivery
    Maria João Gomes, Susana Martins, Bruno Filipe Carmelino Cardoso Sarmento · 2015 · Ageing Research Reviews